CVC, NSSK weigh $3.2bn Kobayashi Pharmaceutical take-private
Friday, September 25, 2026 · first reported by Private Equity Wire
CVC Capital Partners and Nippon Sangyo Suishin Kiko (NSSK) considering joint bid of ~JPY500bn ($3.2bn) to take Japanese healthcare company Kobayashi Pharmaceutical private.
- Firm
- CVC Capital Partners
- Deal value
- $3.2B
- Asset class
- Private equity
- Geography
- Asia-Pacific
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on CVC Capital Partners
- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets